5 alpha-reductase inhibitor treatment for frontal fibrosing alopecia: An evidence-based treatment update
Journal of the European Academy of Dermatology and Venereology Mar 15, 2018
Murad A, et al. - The effectiveness and safety of 5 alpha-reductase inhibitor (5ARI) for the treatment of frontal fibrosing alopecia (FFA) were assessed in this evidence-based analysis. Results demonstrated that it was possible for the subjects treated with 5ARI to achieve either disease stability or reduction in the rate of progression in selected cases.
Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
-
Exclusive Write-ups & Webinars by KOLs
-
Daily Quiz by specialty -
Paid Market Research Surveys -
Case discussions, News & Journals' summaries
